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Abstract 
The use of the MRI systems in healthcare facilities is expanding based on the following observations: 1) patients are not 
exposed to ionizing radiation during MRI examinations (as opposed to computed tomography [CT]) and 2) the imaging 
options available are greater with the use of the MRI than with the x-ray or CT. Due to the high acquisition and 
operating costs of an MRI system, it is necessary to pay special attention to the economic components of MRI use. The 
following recommendations are provided for the rational use of MRI systems in University Hospitals, and are based on 
data originating from one hospital in particular. A detailed analysis of the economics involved with operating an MRI 
system was made, and through this analysis parameters were formulated which describe the financial side of MRI 
operation. This research was done in the context of the reimbursement mechanism of the Czech Republic, and contains 
the calculations and a complete costs and break-even points for each MRI examination. The results are developed 
models for the reimbursement of an MRI in the Czech Republic, and particular recommendations for the rational use of 
an MRI in faculty hospital-type facilities. 
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Introduction 
In this article, the authors recommend the rational 
way of operating MRI imaging systems, especially for 
healthcare establishment such as faculty hospitals. It is 
important to focus on the cost structure of the operation 
and identify the most important influencing factors and 
parameters. To understand the functioning of the entire 
system in more detail, it is necessary to realize the 
overall concept of the Czech Republic healthcare 
services and the position of radiology in this system. 
The data from 2011 are used in the analysis of the 
economy of MRI imaging systems and calculation of 
costs for negotiated services. The break-even analysis 
shows the amount of services necessary to balance 
costs and revenues. 
 
Methods 
Classification of costs is the necessary first step for 
determining the share of contributions of individual 
cost items to the creation of added value, and for 
calculating the prices of related healthcare services (1). 
As the objective of this calculation is a determination 
of prices, the detailed price calculations must be based 
on in-depth cost analyses (2). The calculation methods 
(3), including all components of direct and indirect 
costs or variable and fixed costs (according to the 
methods used), are known as total cost calculations (4). 
Our analysis was based on the partial costs calculation 
(5, 6), which comes from the available methods best 
satisfying the selected criteria (3, 7). The resulting 
prices will be compared with the prices of services, and 
a break-even analysis (8) will be performed. 
 
 
The Model (Pilot) Healthcare 
Establishment 
As the model (pilot) healthcare establishment, the 
faculty hospital was selected, which belongs to the 
largest healthcare establishment in the Czech 
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Republic1. Annually, more than 40,000 patients are 
hospitalized in more than 20 clinics, and approximately 
40 % of them undergo surgery. Moreover, this hospital 
has more than half a million outpatients, performs 
surgeries of “super specialized” levels and uses modern 
diagnostic technologies. 
The radiological clinic covers the complete spectrum 
of radiological activities for diagnostics and therapeutic 
preventive care. It closely cooperates with other 
hospital clinics and offers the use of the state-of-the-art 
diagnostic devices (e.g. two MRI imaging systems and 
CT equipment). In 2011, the clinic realized more than 
10,000 magnetic resonance examinations. 
 
Operation of MRI devices in the healthcare 
establishment 
The workloads of the two MRI devices in the model 
healthcare establishment differ: the workload of one of 
them is 100 % and it has practically no free capacity in 
a two-shift operation, and the extent of utilization of 
the second one is 75 % as its two shifts are not 
completely covered and it is not in full operation 
during the weekends. The model healthcare 
establishment has negotiated capacity with health 
instance companies for 1 ½ MRI devices, even if it 
operates two such devices. The workload of the second 
device is limited by two factors. First, full time 
operation over two shifts is not possible and it would 
not be paid for by the insurance companies, and 
second, this device serves as a reserve. If the 
availability for hospitalized patients is lower than 
necessary, it must be possible to open an additional 
shift in order to prevent prolonged waiting times for 
examinations. Table 1 summarizes the data for 2011.  
 
Tab. 1: Summary table of total costs and revenues of 
MRI in 2011 
 
Cost/Revenue item TCZK 
Medicaments - total 4 148 
Special healthcare material (SHM) 75 
Maintenance - total  2 164 
Other material costs - total  163 
Salaries 6 763 
Insurance 2 333 
Depreciation 8 950  
Overhead total  3 843 
Costs - total 28 438 
Points 37 849 
SAMD 2 288 
Revenues - total 40 137 
 
 
 
 
                                                 
1The healthcare establishment prefers to remain confidential. The 
data used in this paper are based on the annual report. 
Revenues from MRI operation 
The revenues from the MRI operation are 
summarized in Table 2. If the healthcare establishment 
reports a medicament as separately accounted 
medicaments (SAMD) to the health insurance 
company, the insurance company pays costs in addition 
to the cost of an operation, and this item therefore 
appears in both costs (medicaments) and revenues 
(MRI operation). Separately accounted material 
(SAMT) does not occur with the MRI. Item “points” 
include points for performed operations from insurance 
companies, private patients, foreigners and clinical 
studies. The total number of points (approximately 
54,070,000) was converted to CZK by using the unit 
price of 0.70 CZK/point, in compliance with regulatory 
directives. 
 
Tab. 2: Revenues from MRI operation 
 
Revenue item TCZK 
Points 37,849 
SAMT 0 
SAMD 2,288 
Total revenue 40,137 
 
 
 
Table 3 shows that the highest cost items are salaries 
and depreciation due to the high purchase cost of MRI 
devices (Table 4). 
 
Tab. 3: Costs of MRI operation 
 
Cost item TCZK 
Contrasting substances and 
medicaments (total)  
4,148 
Special healthcare material 
(SHM) 
75 
Maintenance total  2,164 
Other material costs total  162 
Salaries 6,763 
Insurance 2,333 
Depreciation 8,950 
Overhead - personnel 541 
Overhead - technical 3,302 
Overhead - total 3,843 
Costs - total 28,438 
 
 
 
Tab. 4: Depreciation of MRI devices 
 
Device specification Monthly 
depreciation (TCZK) 
Magnetic resonance 1 (1.5T) 379 
Magnetic resonance 2 (1.5T) 356 
Average value 367.5 
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Calculation of incomplete (partial) costs 
In 2011, the healthcare establishment contracted with 
the insurance companies for 6 basic types of operations 
using magnetic resonance (89713 – MRI of head, limb, 
joint, one section of the spine [C, TH, or L]; 89715 – 
MRI of neck, chest, abdomen, and pelvis (including 
breast); 89717 – heart MRI; 89723 - MRI angiography; 
89725 – repeated or complementary MRI; 89813 – 
consultation with physician-radiologist). A list of the 
 
descriptions of these operations and some of their 
characteristics from the recording lists, and list of 
operations are presented in Tables 5 and 6. 
The revenue from an operation was determined as 
the sum of two point values: points per operation (from 
the list of operations) and indirect revenue (product of 
operation time and overhead rate per minute). The sum 
of the points is converted to CZK using the unit price 
of 0.70 CZK/point in compliance with the regulatory 
directives.  
 
 
 
 
Tab. 5: Revenues and points per operation 
 
Operation 
code 
Number 
of points 
without 
overhead 
Operation 
duration 
(minutes) 
Overhead 
per 
minute 
Number 
of points 
including 
overhead 
Operation 
revenue  
(CZK) 
89713 4,896 60 2.78 5,065 3,544 
89715 5,008 60 2.78 5,177 3,622 
89717 7,415 90 2.78 7,669 5,366 
89723 5,336 60 2.78 5,505 3,852 
89725 2,606 30 2.78 2,691 1,883 
89813 60 15 2.78 102 71 
 
 
 
 
Table 6 lists the personnel costs of operations and 
Table 7 lists the costs of the contrasting substances. 
These values are used for the calculation of incomplete 
(partial) costs. Individual item costs are determined per 
one minute of operation or one operation (for 
contrasting substances). 
 
 
 
 
Tab. 6: Personnel costs of operations 
 
Operation Time - doctor 
Time - 
other 
personnel 
Total personnel 
costs per 
operation 
89713 60 140 1198.9 
89715 60 140 1198.9 
89717 90 200 1752.3 
89723 90 200 1752.3 
89725 30 90 691.7 
89813 15 10 184.5 
 
 
Direct personnel costs are determined as a product of 
the one-minute personnel cost of those participating in 
the operation and the operation duration. In each 
operation a doctor participates with a one minute rate 
of 9.20 CZK and supporting staff participates with a 
one minute rate of 4.60 CZK. 
 
Direct material costs 
The direct material consumed in an operation 
consists of the contrasting substances and special 
medical materials (SMM). The contrasting substance is 
applied only in the first four operation types. In Table 
7, the most frequently used contrasting substance in a 
specific operation type is emphasized in bold. The 
average cost of the most frequently used substance 
(average value/operation) is then used for the following 
calculations. 
It is assumed that the device is in operation for 365 
days a year in two shifts (16 hours). The annual cost of 
SMM is 75 thousand CZK, i.e. approximately 0.20 
CZK per minute. The total direct material costs are 
given in Table 8. 
 
 
 
 
 
ORIGINAL RESEARCH 
 
22 
 
Tab. 7: Personnel costs of operations 
 
Number of 
89713 
operations 
Contrasting substance Number of packages 
Total cost 
(TCZK) 
Unit cost 
(TCZK) 
Average 
value/operation (TCZK) 
130 MULTIHANCE 10 ML 109 116.27 1.072 0.894 
93 MULTIHANCE 20ML 37 79.569 2.130 0.856 
1 017 GADOVIST 469 1 198.987 2.554 1.179 
3 PRIMOVIST 3 10.519 4.208 3.506 
92 OMNISCAN 10 93.655 9.328 1.018 
1 IOMERON 1 0.693 1.386 0.693 
91 DOTAREM 79 103.527 1.310 1.138 
 
Number of 89715 operations  
6  MULTIHANCE 10 ML 7 6.975 1.073 1.163 
7  MULTIHANCE 20ML 4 9.004 2.119 1.286 
114  GADOVIST 78 199.350 2.554 1.749 
27  PRIMOVIST  27 112.092 4.214 4.152 
7  OMNISCAN  1 6.012 9.543 0.859 
6  DOTAREM 6 7.866 1.311 1.311 
 
Number of 89717 operations  
1 MULTIHANCE 1 1.073 1.073 1.073 
47 GADOVIST 43 109.699 2.554 2.334 
 
Number of 89723 operations  
1 MULTIHANCE 1 1.073 1.073 1.073 
 
 
Tab. 8: Total direct material costs for individual operations 
 
Material Direct material costs for operation types (CZK) 89713  89715  89717  89723  89725  89813  
Contrasting substance 1 179  1 749  2 334 1 073  0  0  
SMM 13  13  19 13  6  3  
Total  1 192  1 762  2 353 1 086  6  3  
 
 
 
The depreciation of the MRI devices was determined 
in Table 4 as the average value for both of them, and 
some of the equipment used in the operations has 
already been depreciated, therefore, there are no costs 
for their depreciation.  
 
 
Tab. 9: Descriptions of figures and tables are of the 
same style. Do not center the description! 
 
Fixed assets Monthly depreciation (CZK) 
Pressure injector Medrad 
Resonance  
760  
Pressure injector 8,500  
Pulse oxymetr 625  
Total  9,719  
 
 
Among them are the air-conditioning unit, non-
magnetic trolley, console Magic View, etc. The 
depreciation of the pressure injector (that is still 
depreciating) is approximately 8,500 CZK/month. The 
corresponding overhead costs for individual operation 
types are given in Table 11. 
 
Tab. 10: Overhead costs per minute of operation 
 
The variable part of 
overheads 
The variable part of 
overheads (CZK)/1 
minute of operation 
Depreciation of MRI device  12.8 
Depreciation of other 
devices used in operation 0.3 
Depreciation of the building  0.1 
Energy consumption  0.5 
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Tab. 11: Overhead costs per minute of operation 
 
Operation Overhead costs (CZK) 89713 89715 89717 89723 89725 89813 
Depreciation of MRI device  765.6 765.6 1 148.40 765.6 382.8 0 
Depreciation of other devices used in operation 20.2 20.2 30.4 20.2 10.1 0 
Depreciation of the building  3.6 3.6 5.5 3.6 1.8 0.9 
Energy consumption  32.7 32.7 49.1 32.7 16.4 8.2 
Total  822.2 822.2 1 233.30 822.2 411.1 9.1 
 
 
 
Tab. 12: Total cost calculations 
 
Cost item Cost (CZK) 
89713 89715 89717 89723 89725 89813 
Operation cost (including overhead)  3 544 3 622 5 366 3 852 1 883 71 
1) Direct material 13 13 19 13 6 3 
2) Direct personnel costs 1 199 1 199 1 752 1 752 692 184 
3)Overhead contribution  822 822 1 233 822 411 9 
Total direct cost (1+2+3) 2 034 2 034 3 005 2 587 1 109 197 
Revenue 3 544 3 622 5 366 3 852 1 883 71 
Profit = revenue – direct cost  1 510 1 588 2 361 1 264 774 -125 
profit / revenue 43 % 44 % 44 % 33 % 41 % -176 % 
 
 
 
The depreciation of the MRI device and other 
equipment cannot be allocated to operation type 89813, 
as it is only a consultation of findings with a 
radiologist. 
 
Determination of break-even point for individual 
examinations. 
 
Table 13 presents the results of the break-even 
analysis. Break-even is defined as the point at which 
the cost equals the revenue, and it means that from this 
point on the operation is profitable (9, 10). 
The fixed cost of individual operations was 
determined for each operation as the share of the total 
fixed cost corresponding to the share of the number of 
specific operations to the total number of operations 
performed in 2011. The total fixed cost includes 
personnel costs (9,096 TCZK), depreciation (4,475 
TCZK) and overhead. 
 
 
Tab. 13: Break-even points for individual operations 
 
Items for break-even point calculation  
 
Operation code 
89713 89715 89717 89723 89725 89813 
Fixed cost  8 646 862 658 908 84 978 605 306 7 251 911 7 251 911 
Operation revenue  3 544 3 622 5 366 3 852 1 883 1 883 
Variable cost  2 034 2 034 3 005 2 587 1 109 1 109 
Break-even point  5 727 415 36 479 9 372 9 372 
 
 
 
Conclusions and Recommendations 
for Rational Operation of MRI 
Devices 
On the basis of the 2011 data, it can be concluded 
that the operation of MRI devices is profitable. With 
13,500 examinations and 21,011 in total revenues, they 
profit at more than 1.4 times higher than the 
corresponding costs. The highest components of the 
cost are depreciation, personnel costs and 
medicaments. The purchase prices of MRI devices are 
high (34 to 45 million CZK), resulting in a high 
depreciation (31 % of the total costs), and saving 
depreciation costs is not possible. 
The third highest cost component was the cost of 
contrasting substances. Their purchase price was 4,148 
TCZK, while the amount obtained in this instance was 
only 2,288, indicating that the difference between the 
cost and revenue is more than 2 million CZK. The 
price of the other medicaments used in the 
examinations is negligible in relation to the contrasting 
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substances (approximately 0.5 %) and cannot 
significantly contribute to such a loss. The cause of this 
difference was found in the reporting of the 
consumption of the contrasting substance: the hospital 
purchased the complete package of the substance, 
however only a part of it (e.g. half) is really used in the 
examination, and the rest is disposed of. The hospital 
then reports to the health insurance only the amount 
used in the examination, and the unused amount is not 
paid for. It is therefore recommended that the entire 
amount be reported to the health insurance company 
since the entire package is being consumed and the rest 
of the contrasting substance cannot be used for another 
patient. This approach should be combined with 
decisions about the types of contrast substance 
packaging. It can also be recommended that increased 
attention be paid to the delivery of the contrasting 
substance to the patient before the examination. The 
correct insertion of the winged infusion set reduces the 
loss of contrasting substance which can be caused by 
improper manipulation. 
 Currently, faculty-type hospitals often operate two 
or more MRI devices (usually one of them is older, and 
the second is purchased either as an upgrade or for 
additional capacity). If these devices are mutually 
interchangeable, the contracts with insurance 
companies cover only the actually used capacity; 
therefore, these imaging systems should be fully 
utilized, especially in the case of long waiting times. 
The contracts should cover the full costs of all devices, 
which require the hiring of new employees, and 
therefore an increase in personnel costs. On the other 
hand, the revenues would also increase (by 25 % in the 
investigated case).  
An analysis of the cost structure can lead to the 
increased efficiency of MRI operation, and assist in 
decisions about which examinations (and to what 
extent) should be performed.  
 
 
Tab. 14: Break-even points for individual operations 
 
Problem Recommended solution  Impact of changes 
Incorrect reporting of 
contrasting 
substances  
The healthcare establishment should report the consumption of 
whole packaging if the rest of the substance cannot be used for 
other patients. Currently, the “wasted” substance is not paid for by 
the insurance company. Elimination of 
2 million CZK loss 
for medicaments  Type of contrasting 
substance packaging 
The investigated healthcare establishment should prioritize the 
purchase of contrasting substances in bottles. For hygienic reasons, 
the contrasting substance in syringes can only be applied to one 
patient and the rest must be “wasted”. Bottled contrasting 
substances can be divided among more patients practically without 
loss and additional cost. 
The capacity of 
devices not fully used  
Negotiating contracts with insurance companies for the full capacity 
of both MRI devices (currently the full capacity is not paid for). 
Increase of 
revenues by 25 % 
 
 
 
It is important to determine how each individual 
operation contributes to the costs and revenues, and if 
the contribution is determined to be negative, then even 
variable costs are not covered.If it is zero, the revenues 
should equal the costs, however there is no contribution 
for covering the fixed costs. Ideally, the contribution 
should be positive. In our case, the contributions of all 
types of operations (except 89813) were positive, and 
since the share of 89813 operations is rather low (51 
times less than 89713, and 43 times less than 89725), 
this small negative contribution is more than 
compensated for by operations of other types. The 
contributions of operations of 89717 and 89715 are the 
highest and should have the largest share among all 
operations. 
 
Conclusion 
With payments of 0.70 CZK per point, the profit 
margin of MRI devices is nearly 50 % and is one of the 
highest in the public healthcare insurance system. The 
cost items of MRI operations, namely the three highest 
(personnel costs, depreciation and costs of 
medicaments), and possibilities of their decrease were 
investigated, and it was found that the only item for 
which the costs could be influenced, is the 
medicaments. 
The parameters highly influencing the MRI economy 
are those related to the reimbursement mechanism, in 
particular the allocation of points per operation and 
price per point. These influence the revenues, and if 
they are changed a profitable activity can turn into a 
losing one. Constant and unpredictable changes in 
these mechanisms and parameters make long-term 
planning impossible. 
The recommendations for rational operation are 
focused mainly on a change in reporting the 
consumption of contrasting substances. It is 
recommended that the hospital report the consumption 
of the entire package if the extra must be wasted. It is 
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also recommended that the hospital purchase bottled 
contrasting substances instead of syringes. The last 
recommendation relates to negotiating contracts with 
the insurance companies to cover the full capacity of 
both MRI devices, and increase their operation time by 
25 %. These cost calculations should be integrated into 
the managerial decision-making processes.  
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